G Lu

Summary

Affiliation: University of Bristol
Country: UK

Publications

  1. ncbi Combination of direct and indirect evidence in mixed treatment comparisons
    G Lu
    MRC HSRC, Department of Social Medicine, University of Bristol, Canynge Hall, White Ladies Road, Bristol BS8 2PR, U K
    Stat Med 23:3105-24. 2004
  2. ncbi Mapping from Disease-Specific to Generic Health-Related Quality-of-Life Scales: A Common Factor Model
    Guobing Lu
    School of Social and Community Medicine, University of Bristol, Bristol, UK Electronic address
    Value Health 16:177-84. 2013
  3. ncbi Meta-analysis of mixed treatment comparisons at multiple follow-up times
    G Lu
    MRC Health Services Research Collaboration, University of Bristol, Bristol, UK
    Stat Med 26:3681-99. 2007
  4. ncbi Modeling between-trial variance structure in mixed treatment comparisons
    Guobing Lu
    Department of Community Based Medicine, University of Bristol, Cotham House, Cotham Hill, Bristol BS6 6JL, UK
    Biostatistics 10:792-805. 2009
  5. ncbi Mixed treatment comparison with multiple outcomes reported inconsistently across trials: evaluation of antivirals for treatment of influenza A and B
    N J Welton
    Academic Unit of Primary Health Care, Department of Community Based Medicine, University of Bristol, Cotham House, Cotham Hill, Bristol BS6 6JL, U K
    Stat Med 27:5620-39. 2008
  6. ncbi Expected value of sample information calculations in medical decision modeling
    A E Ades
    Medical Research Council Health Services Research Collaboration, Bristol, United Kingdom
    Med Decis Making 24:207-27. 2004
  7. ncbi The interpretation of random-effects meta-analysis in decision models
    A E Ades
    Medical Research Council, Health Services Research Collaboration, Canynge Hall, Bristol, UK
    Med Decis Making 25:646-54. 2005
  8. ncbi Correction: interpretation of random effects meta-analysis in decision models
    N J Welton
    Med Decis Making 27:212-4. 2007
  9. ncbi Expression of cyclooxygenase-2, vascular endothelial growth factor and matrix metalloproteinase-2 in patients with primary laryngeal carcinoma: a tissue microarray study
    P Dong
    Department of Otolaryngology Head and Neck Surgery, Shanghai Jiao Tong University, Affiliated Shanghai First People s Hospital, China
    J Laryngol Otol 121:1177-83. 2007

Detail Information

Publications9

  1. ncbi Combination of direct and indirect evidence in mixed treatment comparisons
    G Lu
    MRC HSRC, Department of Social Medicine, University of Bristol, Canynge Hall, White Ladies Road, Bristol BS8 2PR, U K
    Stat Med 23:3105-24. 2004
    ..We discuss model critique and model selection, illustrating the role of Bayesian deviance analysis, and node-based model criticism. The assumptions underlying the MTC models and their parameterization are also discussed...
  2. ncbi Mapping from Disease-Specific to Generic Health-Related Quality-of-Life Scales: A Common Factor Model
    Guobing Lu
    School of Social and Community Medicine, University of Bristol, Bristol, UK Electronic address
    Value Health 16:177-84. 2013
    ..To develop a coherent method for estimating mappings between treatment effects on disease-specific measurement (DSM) instruments and generic health-related quality-of-life (QOL) measures, when both are subject to measurement errors...
  3. ncbi Meta-analysis of mixed treatment comparisons at multiple follow-up times
    G Lu
    MRC Health Services Research Collaboration, University of Bristol, Bristol, UK
    Stat Med 26:3681-99. 2007
    ..The extent of between-trials heterogeneity in treatment effects depends on treatment contrast. In discussion we note that models of this type have a very wide potential application...
  4. ncbi Modeling between-trial variance structure in mixed treatment comparisons
    Guobing Lu
    Department of Community Based Medicine, University of Bristol, Cotham House, Cotham Hill, Bristol BS6 6JL, UK
    Biostatistics 10:792-805. 2009
    ..The procedure is implemented in a MCMC framework and illustrated with example data sets from medical research practice...
  5. ncbi Mixed treatment comparison with multiple outcomes reported inconsistently across trials: evaluation of antivirals for treatment of influenza A and B
    N J Welton
    Academic Unit of Primary Health Care, Department of Community Based Medicine, University of Bristol, Cotham House, Cotham Hill, Bristol BS6 6JL, U K
    Stat Med 27:5620-39. 2008
    ....
  6. ncbi Expected value of sample information calculations in medical decision modeling
    A E Ades
    Medical Research Council Health Services Research Collaboration, Bristol, United Kingdom
    Med Decis Making 24:207-27. 2004
    ..Illustrative worked examples of EVSI calculations are given in an appendix...
  7. ncbi The interpretation of random-effects meta-analysis in decision models
    A E Ades
    Medical Research Council, Health Services Research Collaboration, Canynge Hall, Bristol, UK
    Med Decis Making 25:646-54. 2005
    ....
  8. ncbi Correction: interpretation of random effects meta-analysis in decision models
    N J Welton
    Med Decis Making 27:212-4. 2007
  9. ncbi Expression of cyclooxygenase-2, vascular endothelial growth factor and matrix metalloproteinase-2 in patients with primary laryngeal carcinoma: a tissue microarray study
    P Dong
    Department of Otolaryngology Head and Neck Surgery, Shanghai Jiao Tong University, Affiliated Shanghai First People s Hospital, China
    J Laryngol Otol 121:1177-83. 2007
    ..To determine the correlation between expression of cyclooxygenase-2, vascular endothelial growth factor and matrix metalloproteinase-2, in patients with laryngeal carcinoma...